Amylyx Pharmaceuticals Inc share price logo

Amylyx Pharmaceuticals Inc

NASDAQ: AMLX

Mid Cap

$32.41

-1.53

(-4.51%)

as on

Amylyx Pharmaceuticals Inc Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $32.25
    $34.10
    downward going graph

    0.49%

    Downside

    5.21%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $10.83
    $41.14
    downward going graph

    66.58%

    Downside

    26.94%

    Upside

    downward going graph

Amylyx Pharmaceuticals Inc share price movements today

Previous Close
$33.94
Open
$34.10
Volume
744.3K
Market Cap
$4.2B
Day's Low - High
$32.25 - $34.10
52 Week Low - High
$10.83 - $41.14

Amylyx Pharmaceuticals Inc Historical Returns

1 Month Return
-12.07 %
3 Month Return
+ 116.59 %
1 Year Return
+ 155 %
3 Year Return
+ 79.77 %
5 Year Return
0 %

Amylyx Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Amylyx Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.2B

EPS (TTM)

-1.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-24.07

Industry PE ratio

29.81

PEG Ratio

-0.4066024413117878

EBITDA

-149.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-52.92%

Amylyx Pharmaceuticals Inc Stock Valuation

Track how Amylyx Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Amylyx Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (-12.39x)

December 31, 2022

Today (-7.90x)

December 31, 2025

Industry (29.81x)

December 31, 2025

Highest (20.09x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -7.90x

Amylyx Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.2BNA-24.070.00%0.00%
BUY$21.3B148.54%16.5586.14%0.00%
HOLD$19.1B26.23%-47.5834.83%2.82%
BUY$40.0BNA18.7765.57%1.35%
BUY$30.3B-63.21%12.0170.87%2.86%

Stock Returns calculator for Amylyx Pharmaceuticals Inc Stock including INR - Dollar returns

The Amylyx Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Amylyx Pharmaceuticals Inc investment value today

Current value as on today

₹2,64,665

Returns

₹1,64,665

(+164.67%)

Returns from Amylyx Pharmaceuticals Inc Stock

₹1,43,501 (+143.5%)

Dollar Impact

₹21,164 (+21.16%)

Analyst Recommendation on Amylyx Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals Inc. Average target price of $42.36

Amylyx Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals Inc.

What analysts predicted

23.49%UPSIDE

Target Price

$42.36

Current Price

$32.41

Analyzed by

9 Analysts

Target

$42.36

Amylyx Pharmaceuticals Inc target price $42.36, a slight upside of 23.49% compared to current price of $32.41. According to 9 analysts rating.

Indian Investors' Interest in Amylyx Pharmaceuticals Inc Stock

Search interest for Amylyx Pharmaceuticals Inc Stock has increased by 2210% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2210% versus previous 30 day period

Amylyx Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
88
-1
0
0
-
-
-
-
-
-
Gross Profit
-27
-8
0
0
-22
0
-19
0
0
-
Operating Income
-122
-53
-75
-40
-37
-42
-36
-36
-43
-45
EBITDA
-118
-72
-72
-38
-35
-41
-34
-30
-41
-43
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-118
-72
-72
-38
-35
-41
-34
-32
-41
-43
Income Tax Expense
0
-
-
0
-
-
-
0
-
-
Net Income
-118
-72
-72
-37
-35
-41
-34
-32
-41
-43
Net Profit Margin
-31.32%
845.45%
-94.47%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Amylyx Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
-
22
380
87
-
Gross Profit
-10
-23
-
19
355
45
0
Operating Income
-13
-39
-82
-201
38
-314
-153
EBITDA
1
-39
-87
-197
55
-290
-144
Interest Expense
1
2
-
-
-
-
-
Depreciation
13
0
0
0
1
0
0
Income Before Tax
-13
-42
-87
-197
54
-302
-144
Income Tax Expense
-
-
-
0
5
0
0
Net Income
-14
-42
-87
-198
49
-301
-144
Net Profit Margin
-734.43%
-3683.69%
0.00%
86.54%
93.32%
51.75%
0.00%

Amylyx Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-118
-72
-72
-37
-35
-41
-34
-32
-41
-43
Operating Cash Flow
0
-66
-41
-59
-39
-25
-30
-27
-36
-31
Investing Cash Flow
0
-28
38
64
-43
22
5
29
36
-149
Financing Cash Flow
0
0
0
0
65
0
191
0
3
1
Change in Cash
0
-95
-2
5
-17
-1
167
1
2
-179

Amylyx Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-42
-87
-198
49
-301
-144
Operating Cash Flow
-10
-36
-74
-179
11
-167
-123
Investing Cash Flow
-
0
-46
-238
92
75
14
Financing Cash Flow
0
46
158
431
3
0
257
Change in Cash
3
9
37
12
107
-92
148

Mutual Funds that own Amylyx Pharmaceuticals Inc Stock

Check out the Mutual Funds with significant holdings in Amylyx Pharmaceuticals Inc.

Funds
Holdings
Shares Held
Fidelity Securities Fund
3.609486%
4530377
VANGUARD INDEX FUNDS
3.21522%
4035521
Fidelity Advisor Series VII
2.508265%
3148200
Fidelity Select Portfolios
2.308425%
2897375
MUTUAL FUND SERIES TRUST
1.205009%
1512444

Global Institutional Holdings in Amylyx Pharmaceuticals Inc

Funds
Holdings
Joseph Edelman
6.64%
Vanguard
4.84%
iShares
4.37%
Xtrackers
3.18%
Richard Driehaus
2.42%

Amylyx Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 06:30 PM

    -

    Amylyx Pharmaceuticals to present at the Morgan Stanley Global Healthcare Conference on September 15, 2026.

    Wed, 02:48 AM

    -

    Amylyx Pharmaceuticals signs long-term manufacturing deal for avexitide, enhancing supply chain reliability and operational readiness.

Insights on Amylyx Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AMLX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AMLX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, AMLX stock has moved up by 106.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -32.99M → -43.42M (in $), with an average decrease of 15.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter

About Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
OrganisationAmylyx Pharmaceuticals Inc
Headquarters55 Cambridge Parkway, Cambridge, MA, 02142, US
IndustryBiotechnology
CEOJoshua Cohen
E-voting on sharesClick here to vote

Key Management of Amylyx Pharmaceuticals Inc

Name

Title

Ms. Lindsey Allen

Head of Investor Relations & Communications

Ms. Linda A. Arsenault

Chief Human Resources Officer

Ms. Tammy Sarnelli

Global Head of Regulatory Affairs

Dr. Machelle Manuel Ph.D.

VP & Head of Global Medical Affairs

Mr. Justin B. Klee

Co-CEO & Director

Mr. James M. Frates M.B.A.

Chief Financial Officer

Mr. Tom Holmes

Chief Technical Operations Officer

Mr. Joshua B. Cohen

Co-Founder, Co-CEO & Director

Dr. Camille L. Bedrosian M.D.

Chief Medical Officer

Ms. Gina M. Mazzariello J.D.

Chief Legal Officer & General Counsel

FAQs

What is Amylyx Pharmaceuticals Inc share price today?

Amylyx Pharmaceuticals Inc share price today is $32.41 as on at the close of the market. Amylyx Pharmaceuticals Inc share today touched a day high of $34.10 and a low of $32.25.

What is the 52 week high and 52 week low for Amylyx Pharmaceuticals Inc share?

Amylyx Pharmaceuticals Inc share touched a 52 week high of $41.14 on and a 52 week low of $10.83 on . Amylyx Pharmaceuticals Inc stock price today i.e. is closed at $32.41,which is 21.22% down from its 52 week high and 199.26% up from its 52 week low.

What is Amylyx Pharmaceuticals Inc's market capitalisation today?

Amylyx Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Amylyx Pharmaceuticals Inc Stock (AMLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amylyx Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amylyx Pharmaceuticals Inc Shares that will get you 0.0463 shares as per Amylyx Pharmaceuticals Inc share price of $32.41 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Amylyx Pharmaceuticals Inc Stock (AMLX) from India?

Indian investors can start investing in Amylyx Pharmaceuticals Inc (AMLX) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Amylyx Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Amylyx Pharmaceuticals Inc share’s latest price of $32.41 as on September 19, 2026 at 8:45 am IST, you will get 0.3085 shares of Amylyx Pharmaceuticals Inc. Learn more about fractional shares .